Viromed Medical AG (FRA:VME) GF Score: 22/100 (As of Jul. 03, 2026) — Near Median


FRA:VME Viromed Medical AG FRA:VME
22 GF Score
Price €6.80
! 5 Warning Signs
View Full Analysis

What is Viromed Medical AG GF Score?

Viromed Medical AG FRA:VME +0.74% 22 GF Score is 22 as of Jul. 03, 2026, which is at its 10-year median of 22.00. GuruFocus rates FRA:VME with a GF Score™ of 22/100. The stock has 5 warning signs investors should review.

Viromed Medical AG has the GF Score of 22, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 8/10
2. Profitability Rank : 2/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 0/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Viromed Medical AG might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Viromed Medical AG  (FRA:VME) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Viromed Medical AG GF Score Related Terms

FRA:VME vs ABT, SYK, MDT: GF Score Comparison

For the Medical Devices subindustry, Viromed Medical AG's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Viromed Medical AG GF Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Viromed Medical AG's GF Score distribution charts can be found below:

* The bar in red indicates where Viromed Medical AG's GF Score falls into.


FRA:VME
22GF Score
Viromed Medical AG FRA:VME
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 22 mean?
Viromed Medical AG (FRA:VME) has a GF Score of 22 as of Jul. 03, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Viromed Medical AG and its competitors. This is near median its historical median of 22.00. Over the past decade, Viromed Medical AG's GF Score has ranged from 22.00 to 24.00.
Is Viromed Medical AG's GF Score too high?
Viromed Medical AG's current GF Score of 22 is near median its 10-year median of 22.00. Over the past 10 years, this metric has ranged from a low of 22.00 to a high of 24.00. Overall, Viromed Medical AG has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's GF Score compare to ABT and SYK?
Viromed Medical AG's GF Score of 22 can be compared against companies in the Medical Devices & Instruments industry. Historically, Viromed Medical AG's own GF Score has ranged from 22.00 to 24.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Viromed Medical AG and its competitors. Viromed Medical AG's current GF Score is 22, which is near median its own 10-year median of 22.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (FRA:VME) has a current GF Score of 22. The current GF Score is 22, which is near median its 10-year median of 22.00. Viromed Medical AG's overall GF Score™ is 22/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Viromed Medical AG (FRA:VME), the current GF Score is 22 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Viromed Medical AG Business Description

Other Exchanges VME:Germany
Address Hauptstrasse 105, Rellingen, Pinneberg, SH, DEU, 25462
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
22GF Score

Get the complete analysis for FRA:VME

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.80
Price